CG Oncology, Inc.
CGON
Jodie situation report
CG Oncology, Inc.'s move is being confirmed by its market group.
CGON accounts for 11.2% of the group's measured movement across 6.0 effective names. raw member direction is mixed; 6 of 8 SPY-adjusted paths align to the downside. Capital-flow agreement is 15%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
IBRX, BBIO, ARWR moved materially before CGON. CGON crossed its material path threshold at 11:50 ET, 45 minutes after the first measured mover. BEAM followed.
5 of 8 members in Gene Editing Therapies are active. 0 of 4 disclosed connections are confirming.
- At least 6 of 8 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as RLYB begins moving with the group.
Invalidation: The live read weakens if participation falls to 2 of 8 members or fewer.
Who this business touches
The relationships behind CGON
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
JEFJefferies Financial Group Inc.investeeMay 8, 2026 ▾
“On March 28, 2025, we entered into an Open Market Sale Agreement SM (Jefferies Sales Agreement) with Jefferies LLC, as agent, pursuant to which we may offer and sell, from time to time through Jefferies, shares of our common stock.”
MRKMerck & Company, Inc.partnerFeb 27, 2026 ▾
“We entered into a clinical trial collaboration and supply agreement with Merck providing at no-cost supply of pembrolizumab for use in CORE-001 (which agreement also provides for the joint ownership of clinical trial data but has no additional financial oblig…”
Depended on by
URGNUroGen Pharma Ltd.competitorMar 2, 2026 ▾
“We are aware of several pharmaceutical companies that are developing drugs in the general fields of urology and uro-oncology, such as AstraZeneca, Aura Biosciences., Bristol Myers Squibb, CG Oncology, enGene Holdings, Ferring Pharmaceuticals, Fidia Pharmaceut…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
CGON is currently a Early Follower in the organic co-movement group Gene Editing Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.